Mingdong Huang Selected Research

Vascular System Injuries

1/2017	A long-acting PAI-1 inhibitor reduces thrombus formation.
10/2016	A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
7/2012	Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of β3 integrins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingdong Huang Research Topics

Disease

56	Neoplasms (Cancer) 04/2024 - 02/2006
16	Thrombosis (Thrombus) 04/2023 - 06/2005
12	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2006
9	Infections 04/2022 - 04/2008
8	Inflammation (Inflammations) 01/2024 - 02/2006
7	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2012
5	Hemorrhage 03/2024 - 06/2005
4	Ischemic Stroke 12/2023 - 03/2016
4	COVID-19 10/2023 - 01/2021
4	Autolysis 01/2021 - 08/2011
3	Phototoxic Dermatitis (Phototoxicity) 04/2024 - 01/2012
3	Vascular System Injuries 01/2017 - 07/2012
2	Stroke (Strokes) 03/2024 - 04/2023
2	Carcinogenesis 11/2023 - 09/2009
2	Triple Negative Breast Neoplasms 01/2023 - 09/2020
2	Virus Diseases (Viral Diseases) 10/2021 - 02/2017
2	Sepsis (Septicemia) 10/2020 - 03/2015
2	Pathologic Processes 01/2020 - 02/2006
2	Hemophilia A (Haemophilia) 07/2019 - 04/2008
2	Carcinoma (Carcinomatosis) 10/2018 - 01/2012
2	Myocardial Infarction 03/2016 - 03/2015
2	Body Weight (Weight, Body) 09/2015 - 04/2015
1	Hemorrhagic Stroke 03/2024
1	Cerebral Hemorrhage 03/2024
1	Acute Lung Injury 01/2024
1	Hemolysis 10/2023
1	Infarction (Infarctions) 04/2023
1	Embolism (Embolus) 04/2023
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 04/2023
1	Hematologic Neoplasms (Hematological Malignancy) 03/2023
1	Polyps 01/2023
1	Wounds and Injuries (Trauma) 04/2022

Drug/Important Bio-Agent (IBA)

26	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2023 - 02/2006
13	Photosensitizing Agents (Photosensitizers)IBA 10/2021 - 06/2010
13	Urokinase Plasminogen Activator ReceptorsIBA 01/2021 - 01/2007
12	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 06/2010
9	Serine Proteases (Serine Protease)IBA 01/2023 - 06/2011
7	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2014
7	AlbuminsIBA 10/2023 - 01/2015
7	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2013
6	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2024 - 03/2016
6	Plasminogen Activator Inhibitor 1IBA 12/2023 - 10/2016
6	Protein Disulfide-IsomerasesIBA 12/2022 - 07/2012
6	Plasminogen Activators (Plasminogen Activator)IBA 10/2022 - 02/2006
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2024 - 03/2016
5	Human Serum Albumin FDA LinkGeneric 01/2023 - 09/2015
5	Peptides (Polypeptides)IBA 01/2023 - 01/2019
5	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 10/2018 - 01/2012
5	FibrinIBA 10/2016 - 07/2012
4	Rutin (Rutoside)IBA 04/2023 - 09/2015
4	Drug CarriersIBA 03/2023 - 01/2014
4	Fibrinolysin FDA Link 01/2022 - 04/2010
4	matriptaseIBA 10/2021 - 06/2011
3	Matrix Metalloproteinases (MMPs)IBA 04/2024 - 01/2019
3	IntegrinsIBA 01/2024 - 07/2012
3	phthalocyanineIBA 10/2023 - 06/2010
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2014
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2021 - 01/2020
3	AnticoagulantsIBA 01/2021 - 06/2005
3	EnzymesIBA 01/2020 - 11/2011
3	trypsin-like serine proteaseIBA 12/2019 - 01/2017
3	Cell Surface ReceptorsIBA 01/2019 - 01/2015
3	Monoclonal AntibodiesIBA 01/2019 - 08/2011
2	endoplasmic reticulum glycoprotein p72IBA 01/2024 - 01/2022
2	LipopolysaccharidesIBA 01/2024 - 10/2020
2	Quaternary Ammonium CompoundsIBA 10/2023 - 12/2022
2	Plasminogen InactivatorsIBA 04/2023 - 01/2020
2	AntibodiesIBA 01/2023 - 08/2011
2	nafamostatIBA 01/2023 - 10/2022
2	IsomerasesIBA 01/2022 - 05/2018
2	Sulfhydryl Compounds (Thiols)IBA 01/2022 - 05/2018
2	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2021
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2021 - 10/2011
2	Amiloride (Midamor)FDA LinkGeneric 12/2019 - 01/2018
2	DiureticsIBA 12/2019 - 01/2018
2	Factor VIII (Coagulation Factor VIII)IBA 07/2019 - 04/2008
2	polydopamineIBA 01/2019 - 05/2018
2	Therapeutic UsesIBA 08/2018 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016 - 01/2015
2	PlasminogenIBA 03/2016 - 10/2007
2	LigandsIBA 03/2015 - 01/2014
2	EpitopesIBA 01/2014 - 08/2011
2	Glycoside Hydrolases (Endoglycosidases)IBA 10/2008 - 04/2007
1	Chitinase-3-Like Protein 1IBA 11/2023
1	Glycoproteins (Glycoprotein)IBA 11/2023
1	ChitinasesIBA 11/2023
1	Phosphates (Orthophosphate)IBA 01/2023
1	PolymersIBA 01/2023
1	Hemostatics (Antihemorrhagics)IBA 01/2023
1	AnhydridesIBA 01/2023
1	PolyphosphatesIBA 01/2023
1	Disinfectants (Biocides)IBA 12/2022
1	LipidsIBA 12/2022
1	ferric chlorideIBA 12/2022
1	IonsIBA 04/2022

Therapy/Procedure

16	Therapeutics 12/2023 - 10/2007
12	Photochemotherapy (Photodynamic Therapy) 01/2020 - 06/2010
5	Drug Therapy (Chemotherapy) 01/2020 - 10/2014
4	Lasers (Laser) 01/2017 - 07/2012
3	Precision Medicine 10/2018 - 06/2015